![](/img/cover-not-exists.png)
PCV70 - EFFECT OF TIME IN THERAPEUTIC RANGE ON COST AND CLINICAL OUTCOMES OF ATRIAL FIBRILATION PATIENTS : A COST-CONSEQUENCES ANALYSIS OF RIVAROXABAN VS WARFARIN FOR TURKEY
Kockaya, G., Cavus, F., Ozin, B., Yilmaz, K.C., Ciftci, O., Oguzhan Ergın, G., Sharaf, A., Buyuktuna, N., Buyukisik, T., Saylan, M.Volume:
21
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.09.617
Date:
October, 2018
File:
PDF, 383 KB
2018